Aptar and Macquarie University use CFD to study inhaled biologics
Orbital - Aptar Pharma’s advanced Dry Powder Inhaler (DPI) technology
Credit: Aptar Pharma
A three-year Australian Research Council programme will investigate how dry-powder formulations affect aerosol performance, with CFD models being developed to examine particle transport and inhaler performance.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
